Literature DB >> 18467578

AIDS/HIV. A STEP into darkness or light?

John P Moore1, P J Klasse, Matthew J Dolan, Sunil K Ahuja.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18467578     DOI： 10.1126/science.1154258

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  32 in total

1.  HIV-1 Env antibodies: are we in a bind or going blind?

Authors:  John P Moore
Journal:  Nat Med       Date:  2012-03-06       Impact factor: 53.440

2.  Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization.

Authors:  Cheng Cheng; Jason G D Gall; Martha Nason; C Richter King; Richard A Koup; Mario Roederer; M Juliana McElrath; Cecilia A Morgan; Gavin Churchyard; Lindsey R Baden; Ann C Duerr; Michael C Keefer; Barney S Graham; Gary J Nabel
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 3.  How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?

Authors:  Per Johan Klasse; Rogier W Sanders; Andrea Cerutti; John P Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-20       Impact factor: 2.205

4.  The STEP study provides a hint that vaccine induction of the right CD8+ T cell responses can facilitate immune control of HIV.

Authors:  Marcus Altfeld; Philip J Goulder
Journal:  J Infect Dis       Date:  2011-03-15       Impact factor: 5.226

5.  Socioecological influences on community involvement in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Brooke Hixson; Carlos del Rio
Journal:  Vaccine       Date:  2011-06-29       Impact factor: 3.641

6.  Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect.

Authors:  Samantha Brandler; Alice Lepelley; Marion Desdouits; Florence Guivel-Benhassine; Pierre-Emmanuel Ceccaldi; Yves Lévy; Olivier Schwartz; Arnaud Moris
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

7.  An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Dazon Dixon Diallo; Su-I Hou; Takeia Horton; Kayshin Chan; Mark J Mulligan; Carlos del Rio
Journal:  Prev Sci       Date:  2010-06

8.  With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.

Authors:  Meritxell Genescà; Pamela J Skinner; Jung Joo Hong; Jun Li; Ding Lu; Michael B McChesney; Christopher J Miller
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

Review 9.  Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6.

Authors:  M Genescà; M B McChesney; C J Miller
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

10.  Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.

Authors:  Weijing He; Stuart Neil; Hemant Kulkarni; Edward Wright; Brian K Agan; Vincent C Marconi; Matthew J Dolan; Robin A Weiss; Sunil K Ahuja
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.